Medidawn Life Science Private Limited
About Medidawn Life Science Private Limited
Data last updated:
Medidawn Life Science Private Limited is a private limited company based in Burdwan, West Bengal, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2019PTC234819.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Subir Kumar Mondal and Mrinmoyee Palit.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Som Nath Das Khoshbagan 8 R.B. Ghosh Nr Don Studio, Burdwan, West Bengal, India – 713101.
As per the financials filed for FY 2025, the company reported a revenue of ₹80.64 Lakh, a growth of 123% compared to the previous year. For the same year it recorded a net profit of ₹2.02 Lakh (net margin 2.5%) and EBITDA of ₹17.44 Lakh (EBITDA margin 21.6%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years.
Company details
Contact details
Medidawn Life Science Private Limited's registered office is in Burdwan, West Bengal. Its e-mail address is in the company report.
- Email
- Registered AddressSom Nath Das Khoshbagan 8 R.B. Ghosh Nr Don Studio, Burdwan, West Bengal, India – 713101
- IndustryChemicals, Manufacturing, Basic Chemical
To see the full contact details of Medidawn Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medidawn Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medidawn Life Science Private Limited, buy the company report.
Financials of Medidawn Life Science Private Limited
FY 2025 filings availableMedidawn Life Science Private Limited reported revenue of ₹80.64 Lakh (up 123% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 81% over three years, including 123% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.6% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medidawn Life Science Private Limited, buy the company report.
Board of directors of Medidawn Life Science Private Limited
Medidawn Life Science has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subir Kumar Mondal | Director | 19 Nov 2019 | 6 Years 11 Months | Current |
| Mrinmoyee Palit | Director | 19 Nov 2019 | 6 Years 11 Months | Current |
Peer comparison
Medidawn Life Science Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nanoviv Technologies India Private Limited | ₹81.02 Lakh (FY 2024) | 11088.0% | Chennai, Tamil Nadu, India | |||
| Shining Ayurveda Private Limited | ₹80.82 Lakh (FY 2024) | 61.0% | Yamuna Nagar, Haryana, India | |||
| VSK Life Sciences Private Limited | ₹80.78 Lakh (FY 2025) | -16.0% | Hyderabad, Telangana, India | |||
| Shradha Agarbatti Private Limited | ₹80.76 Lakh (FY 2025) | 6.0% | Jagatpur, Odisha, India | |||
| Retenor Life Sciences Private Limited | ₹80.69 Lakh (FY 2024) | 18.0% | Bangalore, Karnataka, India | |||
| Medidawn Life Science Private Limitedthis company | ₹80.64 Lakh (FY 2025) | ₹2.02 Lakh | 2.5% | 123.0% | Burdwan, West Bengal, India | |
| Caresfield Pharmaceutical Private Limited | ₹80.63 Lakh (FY 2025) | -12.0% | Manimajra, Chandigarh, India | |||
| KBH Polymers Private Limited | ₹80.47 Lakh (FY 2025) | -39.0% | Ahmedabad, Gujarat, India | |||
| Classic Soap and Powder Private Limited | ₹80.45 Lakh (FY 2025) | -40.0% | Jaipur, Rajasthan, India | |||
| Shalffeyo Polypack Private Limited | ₹80.44 Lakh (FY 2025) | -85.0% | Jaipur, Rajasthan, India | |||
| Holygolee Pharmacy Private Limited | ₹80.44 Lakh (FY 2025) | -45.0% | New Delhi, Delhi, India |
To see the full peer comparison of Medidawn Life Science Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medidawn Life Science Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medidawn Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medidawn Life Science Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medidawn Life Science Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Rinku Gain ceased to be Director on 18 Apr 2022.
Frequently asked questions
Medidawn Life Science is an active private limited company based in Burdwan, West Bengal, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 November 2019 (7+ years old) and is registered under CIN U24100WB2019PTC234819.
Medidawn Life Science has 2 current directors:
- Subir Kumar Mondal - Director
- Mrinmoyee Palit - Director
The latest financial statements of Medidawn Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Medidawn Life Science is U24100WB2019PTC234819. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medidawn Life Science was incorporated on 19 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Medidawn Life Science by revenue are Nanoviv Technologies India Private Limited, Shining Ayurveda Private Limited, VSK Life Sciences Private Limited, Shradha Agarbatti Private Limited, Retenor Life Sciences Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rinku Gain ceased to be Director on 18 Apr 2022. Prakash Chandra Aich ceased to be Director on 25 Nov 2020. Mrinmoyee Palit was appointed as Director on 19 Nov 2019. Medidawn Life Science has 4 board changes on record in total.
The registered office of Medidawn Life Science is at Som Nath Das Khoshbagan 8 R.B. Ghosh Nr Don Studio, Burdwan, West Bengal, India – 713101.
Medidawn Life Science operates in the chemicals industry, in the manufacturing segment.
Medidawn Life Science can be reached at its registered office: Som Nath Das Khoshbagan 8 R.B. Ghosh Nr Don Studio, Burdwan, West Bengal, India – 713101.
Medidawn Life Science is registered under the jurisdiction of the Registrar of Companies (ROC), Kolkata.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
